Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Aug;11(4):294-301.
doi: 10.1007/s11892-011-0192-0.

Screening for the high-risk foot of ulceration: tests of somatic and autonomic nerve function

Affiliations
Review

Screening for the high-risk foot of ulceration: tests of somatic and autonomic nerve function

Vasiliki Argiana et al. Curr Diab Rep. 2011 Aug.

Abstract

Diabetic foot ulcers affect almost 5% of the patients with diabetes and carry a huge physical, emotional, and financial burden. Almost 80% of amputations in patients with diabetes are preceded by a foot ulcer. The need for simple screening methods for prevention of foot ulcers and amputations is indisputable. Simple tests such as monofilament, tuning fork, vibration perception threshold determination, ankle reflexes, and pinprick sensation alone or in combination have been studied prospectively and can be used for identification of patients at risk. Newer tests examining sudomotor dysfunction and skin dryness have been introduced in recent years. In cross-sectional studies sudomotor dysfunction assessed by either sympathetic skin response or NEUROPAD™ (Miro Verbandstoffe GmbH, Wiehl-Drabenderhöhe, Germany) testing has been consistently associated with foot ulceration. In addition, NEUROPAD™ testing is simple, reproducible, and widely available and has a high sensitivity for the diagnosis of clinical or subclinical diabetic polyneuropathy. Prospective studies are required to establish whether sudomotor dysfunction can predict foot ulcers and if simple methods assessing sudomotor dysfunction (eg, NEUROPAD™ testing) can be included in the screening tests for the prevention of this complication.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Diabetes Care. 2009 Oct;32(10):1896-900 - PubMed
    1. Diabet Med. 2002 May;19(5):377-84 - PubMed
    1. Diabetes Care. 2004 Jun;27(6):1286-93 - PubMed
    1. Diabetes Care. 2004 Jun;27(6):1458-86 - PubMed
    1. Diabet Med. 2008 Apr;25(4):413-8 - PubMed

MeSH terms

LinkOut - more resources